Definitive Healthcare Corp (NAS:DH)

$ 4.73 0.07 (1.5%) Market Cap: 546.42 Mil Enterprise Value: 498.23 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 48/100

Q3 2024 Definitive Healthcare Corp Earnings Call Transcript
Nov 07, 2024

$4.31 (+0.23%)

Earnings
Q2 2024 Definitive Healthcare Corp Earnings Call Transcript
Aug 05, 2024

$3.55 (-4.05%)

Earnings
Q1 2024 Definitive Healthcare Corp Earnings Call Transcript
May 07, 2024

$7.25 (-1.23%)

Earnings
Q4 2023 Definitive Healthcare Corp Earnings Call Transcript
Feb 28, 2024

$9.2 (-1.18%)

Earnings
Q3 2023 Definitive Healthcare Corp Earnings Call Transcript
Nov 02, 2023

$6.06 (+6.32%)

Earnings
Definitive Healthcare Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q2 2023 Definitive Healthcare Corp Earnings Call Transcript
Aug 14, 2023

$10.48 (-0.66%)

Earnings
Definitive Healthcare Corp at William Blair Growth Stock Conference Transcript
Jun 07, 2023
Definitive Healthcare Corp at Stifel Cross Sector Insight Conference Transcript
Jun 06, 2023
Definitive Healthcare Corp at JPMorgan Global Technology, Media and Communications Conference Transcript
May 22, 2023
Q1 2023 Definitive Healthcare Corp Earnings Call Transcript
May 04, 2023

$9.9 (-2.17%)

Earnings
Definitive Healthcare Corp at Raymond James Institutional Investors Conference Transcript
Mar 07, 2023
Q4 2022 Definitive Healthcare Corp Earnings Call Transcript
Feb 23, 2023

$12.1 (+4.22%)

Earnings
Definitive Healthcare Corp at Needham Growth Conference (Virtual) Transcript
Jan 11, 2023
Definitive Healthcare Corp at Credit Suisse Technology Conference Transcript
Nov 29, 2022
Q3 2022 Definitive Healthcare Corp Earnings Call Transcript
Nov 03, 2022

$13.83 (-5.01%)

Earnings
Definitive Healthcare Corp at Goldman Sachs Communacopia + Technology Conference Transcript
Sep 14, 2022
Definitive Healthcare Corp at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022
Definitive Healthcare Corp at Canaccord Genuity Growth Conference Transcript
Aug 10, 2022
Q2 2022 Definitive Healthcare Corp Earnings Call Transcript
Aug 04, 2022

$29.33 (+0.14%)

Earnings
Definitive Healthcare Corp at Stifel Cross Sector Insight Conference Transcript
Jun 07, 2022
Definitive Healthcare Corp at JPMorgan Global Technology, Media & Communications Conference Transcript
May 25, 2022
Q1 2022 Definitive Healthcare Corp Earnings Call Transcript
May 05, 2022

$22.48 (-6.80%)

Earnings
Definitive Healthcare Corp at Raymond James Institutional Investors Conference Transcript
Mar 07, 2022
Q4 2021 Definitive Healthcare Corp Earnings Call Transcript
Feb 23, 2022

$19.65 (-3.44%)

Earnings
Q3 2021 Definitive Healthcare Corp Earnings Call Transcript
Nov 08, 2021

Earnings

Definitive Healthcare Corp at JPMorgan Global Technology, Media and Communications Conference Transcript

May 22, 2023 / 02:00PM GMT

Release Date Price: $9.6 (+3.56%)

Transcript

Kyle Robert Aikman

JPMorgan Chase & Co, Research Division - Research Analyst

Hello, everyone, and welcome. My name is Kyle. I'm on the healthcare technology and distribution team here at JPMorgan. Today, we're thrilled to be welcoming Definitive Healthcare. And I'm joined on stage by CEO, Robert Musslewhite; and CFO, Rick Booth. We're going to kick it off with a Q&A on mind, and I'm happy to take questions later on. But I wanted to just start and explain for everyone in the audience, can you explain who your customers are and how your solutions help them?

Questions & Answers

Robert W. Musslewhite

Definitive Healthcare Corp. - CEO & Director

Sure. So Definitive Healthcare, we'd say we're the leading purveyor of healthcare commercial intelligence. And what that means is we help really any kind of company or organization that cares about selling into or marketing into or having any sort of commercial success or growth in the healthcare market. And by healthcare, we mean any doctor physician group, hospital, health system facility, really

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.